Eukles Asset Management »

Edwards Lifesciences shares owned by Eukles Asset Management

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Eukles Asset Management from 13F filings

Historical chart of Eukles Asset Management investment in Edwards Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Eukles Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Eukles Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.5k 125 76.25
2023-09-30 $8.7k 125 69.28
2023-06-30 $12k 125 94.33
2023-03-31 $10k 125 82.73
2022-12-31 $9.0k 125 72.00

More positions owned by Eukles Asset Management

NVIDIA Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
iShares Russell 1000 Growth ETF MF Closed and MF Open (IWF)
Accenture Plc Class A Common Stock (ACN)
Mastercard Incorporated Class A Common Stock (MA)
Cboe Global Markets Common Stock (CBOE)
Novo Nordisk A/S Sponsored ADR Class B Common Stock (NVO)
United Rentals Common Stock (URI)
Caterpillar Common Stock (CAT)
SPDR Portfolio Short Term Corporate Bond ETF MF Closed and MF Open (SPSB)
Sherwin-Williams Company Common Stock (SHW)
Laboratory Corporation of America Holdings Common Stock (LH)
FactSet Research Systems Common Stock (FDS)
TJX Companies Common Stock (TJX)

View all positions for Eukles Asset Management

Top funds holding Edwards Lifesciences

Vanguard Group
Alliancebernstein
Bank of New York Mellon
Wellington Management Company
Brown Advisory Holdings Incorporated
Norges Bank Investment Management
Jpmorgan Chase & Co
Fisher Investments
Amundi
Henderson Group
Legal & General Group
T. Rowe Price Associates
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Ubs Global Asset Management Americas
Deutsche Bank Aktiengesellschaft

View all funds holding Edwards Lifesciences